Axogen Inc.. (AXGN) NASDAQ

$8.06 0.29 (3.73%)

Market Cap: $335.71M

As of 03/28/24 03:59 PM EDT. Market closed.

(AXGN)

Axogen Inc.. (AXGN)
NASDAQ

$8.06
0.29 (3.73%)

Market Cap: $335.71M

As of 03/28/24 03:59 PM EDT. Market closed.

Add to Portfolio

it's time to rethink nerve repair! axogen (nasdaq: axgn) is a medical products company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration. people suffer traumatic injuries or undergo surgeries that impact the function of their peripheral nerves daily. damage may cause loss of function and feeling. axogen is bringing the science of nerve ... read more

it's time to rethink nerve repair! axogen (nasdaq: axgn) is a medical products company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration. people suffer traumatic injuries or undergo surgeries that impact the function of their peripheral nerves daily. damage may cause loss of function and feeling. axogen is bringing the science of nerve repair to life with its avance® nerve graft which axogen believes is the first and only commercially available allograft for bridging nerve discontinuities, axoguard® nerve connector, a coaptation aid allowing for close approximation of severed nerves, and axoguard® nerve protector that protects nerves during the healing process. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
CEO Compensation (Base)
$575,000
CEO Compensation (Total)
$3.67M
URL
Address
.
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Full Time Employees
418
CEO Compensation (Base)
$575,000
CEO Compensation (Total)
$3.67M
Address
.
PRICE CHART FOR AXOGEN INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$7.77
Previous Close
$7.77
Days Range
$7.57 - $7.79
52 week range
$3.45 - $10.83
Volume
172,095
Avg. Volume (30 days)
378,757
Market Cap
$335.71M
Dividend Yield
-
P/E
-
Shares Outstanding
43,206,246
Open
$7.77
Previous Close
$7.77
Days Range
$7.57 - $7.79
52 week range
$3.45 - $10.83
Volume
172,095
Avg. Volume (30 days)
378,757
Market Cap
$335.71M
Dividend Yield
-
P/E
-
Shares Outstanding
43,206,246
FINANCIAL STATEMENTS FOR AXOGEN INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AXOGEN INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Zaderej Karen L.CEOMar 21, 2024 Sale$7.6839,280301,6701,143,788Mar 25, 2024, 09:43 PM
DeVinney Erick WayneChief Innovation OfficerMar 21, 2024 Sale$7.684,57835,159177,474Mar 25, 2024, 09:40 PM
Scopelianos AngeloChief R&D OfficerMar 21, 2024 Sale$7.686,88152,84657,994Mar 25, 2024, 09:37 PM
Donovan Michael PatrickVP OperationsMar 21, 2024 Sale$7.686,03346,33354,250Mar 25, 2024, 09:22 PM
Donovan Michael PatrickVP OperationsMar 07, 2024 Sale$8.8136,310319,89135,708Mar 08, 2024, 05:33 PM
Freitag Gregory GeneDirectorMar 07, 2024 Sale$9.0025,000225,000271,594Mar 08, 2024, 05:31 PM
MARIANI PETER JEVP & Chief Financial OfficerDec 11, 2023 Sale$7.5012,50093,80974,693Dec 13, 2023, 04:07 PM
MARIANI PETER JEVP & Chief Financial OfficerOct 13, 2023 Option Exercise$4.043,26313,18376,103Oct 13, 2023, 08:30 PM
DeVinney Erick WayneVP Peripheral Nerve ScienceOct 13, 2023 Option Exercise$4.048643,491113,377Oct 13, 2023, 08:29 PM
Donovan Michael PatrickVP OperationsOct 13, 2023 Option Exercise$4.041,4035,66872,018Oct 13, 2023, 08:29 PM
Scopelianos AngeloChief R&D OfficerOct 13, 2023 Option Exercise$4.041,4035,66836,969Oct 13, 2023, 08:28 PM
MARTINEZ MARIA D.Chief Human Resources OfficerOct 13, 2023 Option Exercise$4.041,4035,66830,476Oct 13, 2023, 08:27 PM
Wendell Amy McBrideDirectorSep 06, 2023 Buy$6.2210,00062,24080,342Sep 08, 2023, 04:20 PM
Burke William P. Mr.DirectorAug 24, 2023 Option Exercise$6.316,00037,8606,000Aug 25, 2023, 04:16 PM
Burke William P. Mr.DirectorAug 23, 2023 Buy$6.5610,00065,60010,000Aug 25, 2023, 04:16 PM
NEELS GUIDO JDirectorAug 16, 2023 Buy$6.1110,00061,10068,259Aug 18, 2023, 04:12 PM
Freitag Gregory GeneDirectorJun 01, 2023 Sale$8.7141,980365,780319,615Jun 05, 2023, 06:47 PM
Freitag Gregory GeneDirectorMay 23, 2023 Sale$9.237,46868,899336,755May 24, 2023, 04:12 PM
Wendell Amy McBrideDirectorMay 12, 2023 Option Exercise$9.2228,750265,07563,883May 16, 2023, 04:31 PM
MARTINEZ MARIA D.Chief Human Resources OfficerMar 16, 2023 Option Exercise$8.274,27035,31329,308Mar 20, 2023, 09:18 PM
Donovan Michael PatrickVP OperationsMar 16, 2023 Option Exercise$8.272,76922,90070,850Mar 20, 2023, 09:15 PM
DeVinney Erick WayneVP Peripheral Nerve ScienceMar 16, 2023 Option Exercise$8.272,76922,900112,662Mar 20, 2023, 09:08 PM
Ottinger BradleyGeneral Counsel and CCOMar 16, 2023 Option Exercise$8.272,63421,78323,627Mar 20, 2023, 06:50 PM
Scopelianos AngeloChief R&D OfficerMar 16, 2023 Option Exercise$8.273,90732,31137,512Mar 20, 2023, 06:27 PM
MARIANI PETER JEVP & Chief Financial OfficerMar 16, 2023 Option Exercise$8.277,03858,20475,657Mar 20, 2023, 06:23 PM
MARIANI PETER JEVP & Chief Financial OfficerFeb 01, 2023 Option Exercise$5.0420,940105,53876,495Feb 01, 2023, 06:45 PM
MARIANI PETER JEVP & Chief Financial OfficerJan 31, 2023 Option Exercise$5.0420,939105,53369,875Feb 01, 2023, 06:45 PM
MARIANI PETER JEVP & Chief Financial OfficerJan 30, 2023 Option Exercise$5.0420,939105,53363,047Feb 01, 2023, 06:45 PM
MARIANI PETER JEVP & Chief Financial OfficerFeb 01, 2023 Sale$9.3614,550136,18861,945Feb 01, 2023, 06:45 PM
MARIANI PETER JEVP & Chief Financial OfficerJan 31, 2023 Sale$9.5514,320136,75655,555Feb 01, 2023, 06:45 PM
MARIANI PETER JEVP & Chief Financial OfficerJan 30, 2023 Sale$9.6914,111136,73648,936Feb 01, 2023, 06:45 PM
MARIANI PETER JEVP & Chief Financial OfficerJan 27, 2023 Option Exercise$5.0420,940105,53863,048Jan 27, 2023, 05:53 PM
MARIANI PETER JEVP & Chief Financial OfficerJan 26, 2023 Option Exercise$5.0420,939105,53363,047Jan 27, 2023, 05:53 PM
MARIANI PETER JEVP & Chief Financial OfficerJan 25, 2023 Option Exercise$5.0420,939105,53363,047Jan 27, 2023, 05:53 PM
MARIANI PETER JEVP & Chief Financial OfficerJan 27, 2023 Sale$10.1620,940212,75042,108Jan 27, 2023, 05:53 PM
MARIANI PETER JEVP & Chief Financial OfficerJan 26, 2023 Sale$9.9020,939207,29642,108Jan 27, 2023, 05:53 PM
MARIANI PETER JEVP & Chief Financial OfficerJan 25, 2023 Sale$10.2320,939214,20642,108Jan 27, 2023, 05:53 PM
Donovan Michael PatrickVP OperationsDec 27, 2022 Option Exercise$9.442862,70064,719Dec 29, 2022, 09:01 PM
DeVinney Erick WayneVP Peripheral Nerve ScienceDec 27, 2022 Option Exercise$9.441871,765106,531Dec 29, 2022, 08:56 PM
Billet IsabelleChief Strategy and BD OfficerDec 27, 2022 Option Exercise$9.443273,08725,065Dec 29, 2022, 08:52 PM
MARIANI PETER JEVP & Chief Financial OfficerDec 27, 2022 Option Exercise$9.446496,12742,108Dec 29, 2022, 08:48 PM
MARTINEZ MARIA D.Chief Human Resources OfficerDec 27, 2022 Option Exercise$9.442862,70019,061Dec 29, 2022, 08:44 PM
Scopelianos AngeloChief R&D OfficerDec 27, 2022 Option Exercise$9.442862,70025,958Dec 29, 2022, 08:40 PM
DeVinney Erick WayneVP Peripheral Nerve ScienceDec 27, 2022 Option Exercise$9.4410,784101,801105,968Dec 28, 2022, 09:34 PM
DeVinney Erick WayneVP Peripheral Nerve ScienceDec 27, 2022 Option Exercise$5.0920,000101,800116,752Dec 28, 2022, 09:34 PM
Zaderej Karen L.CEODec 15, 2022 Option Exercise$5.0926,746136,1371,008,295Dec 16, 2022, 04:51 PM
MARIANI PETER JEVP & Chief Financial OfficerDec 14, 2022 Option Exercise$10.938,93097,60540,132Dec 16, 2022, 04:48 PM
MARIANI PETER JEVP & Chief Financial OfficerDec 14, 2022 Option Exercise$5.0419,36497,59549,062Dec 16, 2022, 04:48 PM
MARIANI PETER JEVP & Chief Financial OfficerNov 16, 2022 Sale$11.8810,649126,51029,698Nov 18, 2022, 05:53 PM
Freitag Gregory GeneDirectorNov 14, 2022 Sale$12.7413,000165,620339,583Nov 16, 2022, 04:05 PM
Freitag Gregory GeneDirectorNov 08, 2022 Sale$12.5013,000162,500352,583Nov 10, 2022, 04:09 PM
Freitag Gregory GeneDirectorAug 10, 2022 Sale$9.708,88686,159365,583Aug 11, 2022, 09:50 PM
Freitag Gregory GeneDirectorAug 08, 2022 Sale$10.3713,046135,287374,469Aug 08, 2022, 05:49 PM
Freitag Gregory GeneDirectorAug 04, 2022 Sale$10.6424,000255,360387,515Aug 08, 2022, 05:49 PM
Freitag Gregory GeneDirectorJul 25, 2022 Option Exercise$9.2630,296280,541411,515Jul 26, 2022, 08:42 PM
Freitag Gregory GeneDirectorJul 25, 2022 Option Exercise$3.3883,000280,540441,811Jul 26, 2022, 08:42 PM
Sandberg EricChief Commercial OfficerJul 19, 2022 Option Exercise$8.401,1259,45016,081Jul 20, 2022, 04:07 PM
Scopelianos AngeloChief R&D OfficerJul 19, 2022 Option Exercise$8.406575,51925,094Jul 20, 2022, 04:04 PM
DeVinney Erick WayneVP Peripheral Nerve ScienceJul 19, 2022 Option Exercise$8.404053,40296,752Jul 20, 2022, 04:01 PM
Billet IsabelleChief Strategy and BD OfficerJul 19, 2022 Option Exercise$8.407516,30824,242Jul 20, 2022, 03:58 PM
Donovan Michael PatrickVP OperationsJul 19, 2022 Option Exercise$8.406575,51963,855Jul 20, 2022, 03:56 PM
Zaderej Karen L.CEOJul 19, 2022 Option Exercise$8.409,08176,280981,549Jul 20, 2022, 03:53 PM
MARIANI PETER JEVP & Chief Financial OfficerJul 19, 2022 Option Exercise$8.409477,95540,347Jul 20, 2022, 03:51 PM
MARTINEZ MARIA D.Chief Human Resources OfficerJul 19, 2022 Option Exercise$8.406575,51918,197Jul 20, 2022, 03:48 PM
MARTINEZ MARIA D.Chief Human Resources OfficerMar 16, 2022 Option Exercise$7.973,23925,81516,283Mar 18, 2022, 04:14 PM
Scopelianos AngeloChief R&D OfficerMar 16, 2022 Option Exercise$7.972,77022,07720,180Mar 18, 2022, 04:11 PM
Sandberg EricChief Commercial OfficerMar 16, 2022 Option Exercise$7.971,51212,05112,798Mar 18, 2022, 04:10 PM
Ottinger BradleyGeneral Counsel and CCOMar 16, 2022 Option Exercise$7.976485,1653,073Mar 18, 2022, 04:09 PM
MARIANI PETER JEVP & Chief Financial OfficerMar 16, 2022 Option Exercise$7.972,76922,06934,584Mar 18, 2022, 04:07 PM
Friedman Mark LouisVP Regulatory Affairs & PolicyMar 16, 2022 Option Exercise$7.971,50211,97124,343Mar 18, 2022, 04:06 PM
Donovan Michael PatrickVP OperationsMar 16, 2022 Option Exercise$7.971,51212,05161,941Mar 18, 2022, 04:05 PM
DeVinney Erick WayneVP Peripheral Nerve ScienceMar 16, 2022 Option Exercise$7.971,49711,93192,578Mar 18, 2022, 04:03 PM
Billet IsabelleChief Strategy and BD OfficerMar 16, 2022 Option Exercise$7.972,44719,50321,769Mar 18, 2022, 04:01 PM
Donovan Michael PatrickVP OperationsFeb 22, 2022 Option Exercise$5.2115,00078,15057,453Feb 24, 2022, 04:09 PM
Sandberg EricChief Commercial OfficerFeb 15, 2022 Option Exercise$8.427626,4168,310Feb 17, 2022, 04:12 PM
Scopelianos AngeloChief R&D OfficerFeb 15, 2022 Option Exercise$8.424003,36811,950Feb 17, 2022, 04:11 PM
MARTINEZ MARIA D.Chief Human Resources OfficerFeb 15, 2022 Option Exercise$8.424003,3686,656Feb 17, 2022, 04:10 PM
DeVinney Erick WayneVP Peripheral Nerve ScienceFeb 15, 2022 Option Exercise$8.423573,00688,075Feb 17, 2022, 04:05 PM
Billet IsabelleChief Strategy and BD OfficerFeb 15, 2022 Option Exercise$8.424473,76415,716Feb 17, 2022, 04:03 PM
Zaderej Karen L.CEODec 27, 2021 Option Exercise$9.741,75217,064925,677Dec 29, 2021, 04:33 PM
Scopelianos AngeloChief R&D OfficerDec 27, 2021 Option Exercise$9.742862,78610,984Dec 29, 2021, 04:31 PM
MARTINEZ MARIA D.Chief Human Resources OfficerDec 27, 2021 Option Exercise$9.742862,7865,731Dec 29, 2021, 04:30 PM
MARIANI PETER JEVP & Chief Financial OfficerDec 27, 2021 Option Exercise$9.746486,31224,146Dec 29, 2021, 04:28 PM
Friedman Mark LouisVP Regulatory Affairs & PolicyDec 27, 2021 Option Exercise$9.742862,78617,452Dec 29, 2021, 04:23 PM
Donovan Michael PatrickVP OperationsDec 27, 2021 Option Exercise$9.742862,78641,983Dec 29, 2021, 04:21 PM
DeVinney Erick WayneVP Peripheral Nerve ScienceDec 27, 2021 Option Exercise$9.741871,82187,249Dec 29, 2021, 04:17 PM
Billet IsabelleChief Strategy and BD OfficerDec 27, 2021 Option Exercise$9.743263,17514,184Dec 29, 2021, 04:15 PM
Zaderej Karen L.CEODec 20, 2021 Option Exercise$9.241,24311,485923,029Dec 22, 2021, 04:09 PM
MARIANI PETER JEVP & Chief Financial OfficerDec 20, 2021 Option Exercise$9.247576,99522,169Dec 22, 2021, 04:07 PM
Friedman Mark LouisVP Regulatory Affairs & PolicyDec 20, 2021 Option Exercise$9.249587816,588Dec 22, 2021, 04:06 PM
Donovan Michael PatrickVP OperationsDec 20, 2021 Option Exercise$9.249587841,119Dec 22, 2021, 04:04 PM
DeVinney Erick WayneVP Peripheral Nerve ScienceDec 20, 2021 Option Exercise$9.241441,33186,686Dec 22, 2021, 04:03 PM
DeVinney Erick WayneVP Peripheral Nerve ScienceDec 15, 2021 Option Exercise$8.804,17136,70586,255Dec 17, 2021, 04:02 PM
DeVinney Erick WayneVP Peripheral Nerve ScienceDec 15, 2021 Option Exercise$3.6710,00036,70090,426Dec 17, 2021, 04:02 PM
Zaderej Karen L.CEONov 24, 2021 Option Exercise$8.9552,375468,756921,147Nov 29, 2021, 04:09 PM
Zaderej Karen L.CEOAug 13, 2021 Option Exercise$3.6746,500170,655868,772Aug 16, 2021, 04:10 PM
Zaderej Karen L.CEOAug 12, 2021 Option Exercise$5.098,25442,013822,272Aug 16, 2021, 04:10 PM
Zaderej Karen L.CEOAug 10, 2021 Option Exercise$5.0975,000381,750855,018Aug 10, 2021, 04:52 PM
Zaderej Karen L.CEOAug 06, 2021 Sale$18.4741,000757,194840,262Aug 10, 2021, 04:52 PM
Donovan Michael PatrickVP OperationsJul 21, 2021 Sale$20.041,93538,77740,839Jul 23, 2021, 04:06 PM
DeVinney Erick WayneVP Peripheral Nerve ScienceJul 20, 2021 Option Exercise$19.203927,52680,426Jul 21, 2021, 04:16 PM
Donovan Michael PatrickVP OperationsJul 20, 2021 Option Exercise$19.2063712,23042,774Jul 21, 2021, 04:15 PM
Zaderej Karen L.CEOJul 20, 2021 Option Exercise$19.208,812169,190780,018Jul 21, 2021, 04:15 PM
Sandberg EricChief Commercial OfficerJul 20, 2021 Option Exercise$19.201,09020,9286,541Jul 21, 2021, 04:14 PM
Scopelianos AngeloChief R&D OfficerJul 20, 2021 Option Exercise$19.2063712,23010,120Jul 21, 2021, 04:14 PM
MARIANI PETER JEVP & Chief Financial OfficerJul 20, 2021 Option Exercise$19.2091817,62621,026Jul 21, 2021, 04:14 PM
Billet IsabelleChief Strategy and BD OfficerJul 20, 2021 Option Exercise$19.2072813,97813,360Jul 21, 2021, 04:13 PM
MARTINEZ MARIA D.Chief Human Resources OfficerJul 20, 2021 Option Exercise$19.2063712,2304,867Jul 21, 2021, 04:13 PM
Friedman Mark LouisVP Regulatory Affairs & PolicyJul 20, 2021 Option Exercise$19.2063712,23016,308Jul 21, 2021, 04:12 PM
NEELS GUIDO JDirectorMay 19, 2021 Option Exercise$4.2840,000171,35042,591Jun 07, 2021, 05:25 PM
DeVinney Erick WayneVP of Clin. & Trans. SciencesApr 28, 2021 Option Exercise$2.8610,00028,60078,082Apr 30, 2021, 04:10 PM
Zaderej Karen L.CEOApr 16, 2021 Option Exercise$5.09100,000509,000765,912Apr 20, 2021, 04:09 PM
Zaderej Karen L.CEOMar 25, 2021 Option Exercise$3.6734,500126,615665,912Mar 29, 2021, 04:17 PM
Freitag Gregory GeneDirectorFeb 25, 2021 Sale$22.0624,000529,440228,352Mar 01, 2021, 04:08 PM
Donovan Michael PatrickVP OperationsFeb 18, 2021 Sale$19.151,80834,62340,839Feb 19, 2021, 04:12 PM
Scopelianos AngeloChief R&D OfficerFeb 17, 2021 Option Exercise$18.714067,5967,046Feb 18, 2021, 05:27 PM
Friedman Mark LouisVP, Regulatory & QualityFeb 17, 2021 Option Exercise$18.7095117,78713,936Feb 18, 2021, 05:26 PM
DeVinney Erick WayneVP, Clinical&Translational ScFeb 17, 2021 Option Exercise$18.701,86434,85768,082Feb 18, 2021, 05:26 PM
Sandberg EricChief Commercial OfficerFeb 17, 2021 Option Exercise$18.7090316,8863,223Feb 18, 2021, 05:25 PM
Donovan Michael PatrickVP OperationsFeb 17, 2021 Option Exercise$18.7179714,91242,647Feb 18, 2021, 05:17 PM
Freitag Gregory GeneDirectorFeb 17, 2021 Option Exercise$18.701,57729,490252,352Feb 18, 2021, 05:16 PM
MARTINEZ MARIA D.Chief Human Resources OfficerFeb 17, 2021 Option Exercise$18.714067,5965,584Feb 18, 2021, 05:15 PM
MARIANI PETER JChief Financial OfficerFeb 17, 2021 Option Exercise$18.712,95455,26118,234Feb 18, 2021, 05:15 PM
Zaderej Karen L.CEOFeb 17, 2021 Option Exercise$18.717,686143,805631,412Feb 18, 2021, 05:15 PM
Billet IsabelleChief Strategy and BD OfficerFeb 17, 2021 Option Exercise$18.714548,49411,080Feb 18, 2021, 05:14 PM
Donovan Michael PatrickVP OperationsFeb 05, 2021 Option Exercise$19.815,190102,81440,839Feb 09, 2021, 07:12 PM
Donovan Michael PatrickVP OperationsFeb 05, 2021 Option Exercise$5.1420,000102,80046,029Feb 09, 2021, 07:12 PM
Zaderej Karen L.CEOJan 08, 2021 Sale$20.0065,0001,300,000609,099Jan 12, 2021, 04:08 PM
Donovan Michael PatrickVP OperationsDec 30, 2020 Sale$17.481,73330,29326,029Dec 31, 2020, 04:06 PM
DeVinney Erick WayneVP, Clinical&Translational ScDec 29, 2020 Sale$17.813716,60863,240Dec 30, 2020, 05:33 PM
Donovan Michael PatrickVP OperationsDec 29, 2020 Sale$17.8156710,09827,762Dec 30, 2020, 04:09 PM
Freitag Gregory GeneDirectorDec 29, 2020 Sale$17.8191616,314248,345Dec 30, 2020, 12:53 PM
MARIANI PETER JChief Financial OfficerDec 29, 2020 Sale$17.811,29323,02810,376Dec 30, 2020, 11:56 AM
Scopelianos AngeloVP Research & DevelopmentDec 29, 2020 Sale$17.8156710,0985,529Dec 30, 2020, 11:55 AM
Zaderej Karen L.CEODec 29, 2020 Sale$17.813,50062,335674,099Dec 30, 2020, 11:53 AM
Friedman Mark LouisVP,Regulatory & QualityDec 29, 2020 Sale$17.8156710,09811,124Dec 30, 2020, 11:52 AM
MARTINEZ MARIA D.Chief Human Resources OfficerDec 29, 2020 Sale$17.8156710,0984,665Dec 30, 2020, 11:51 AM
Billet IsabelleChief Strategy and BD OfficerDec 29, 2020 Sale$17.8164911,5599,496Dec 30, 2020, 11:51 AM
Zaderej Karen L.CEODec 23, 2020 Option Exercise$4.8119,37593,194666,094Dec 28, 2020, 09:26 AM
Donovan Michael PatrickVP OperationsDec 22, 2020 Sale$17.192794,79626,029Dec 23, 2020, 02:32 PM
Zaderej Karen L.CEODec 21, 2020 Sale$16.421,27520,936646,719Dec 22, 2020, 05:32 PM
DeVinney Erick WayneVP, Clinical&Translational ScDec 21, 2020 Sale$16.421472,41462,111Dec 22, 2020, 03:22 PM
Freitag Gregory GeneDirectorDec 21, 2020 Sale$16.423796,223245,076Dec 22, 2020, 03:15 PM
Donovan Michael PatrickVP OperationsDec 21, 2020 Sale$16.42961,57626,308Dec 22, 2020, 01:55 PM
MARIANI PETER JChief Financial OfficerDec 21, 2020 Sale$16.424817,8986,419Dec 22, 2020, 12:54 PM
Friedman Mark LouisVP,Regulatory & QualityDec 21, 2020 Sale$16.42961,5768,893Dec 22, 2020, 11:38 AM
DeVinney Erick WayneVP, Clinical&Translational ScDec 15, 2020 Option Exercise$16.504,37372,15561,683Dec 17, 2020, 04:41 PM
DeVinney Erick WayneVP, Clinical&Translational ScDec 15, 2020 Option Exercise$4.8115,00072,15066,056Dec 17, 2020, 04:41 PM
Friedman Mark LouisVP,Regulatory & QualityDec 03, 2020 Option Exercise$3.863,81214,7038,614Dec 07, 2020, 02:39 PM
Donovan Michael PatrickVP OperationsNov 09, 2020 Sale$15.0017,617264,25526,029Nov 12, 2020, 10:14 AM
Zaderej Karen L.CEONov 09, 2020 Sale$14.5314,000203,420644,869Nov 10, 2020, 09:56 AM
MARIANI PETER JChief Financial OfficerOct 30, 2020 Option Exercise$5.0460,000302,40080,683Nov 03, 2020, 05:11 PM
MARIANI PETER JChief Financial OfficerOct 30, 2020 Sale$12.4175,683939,35320,683Nov 03, 2020, 05:11 PM
Freitag Gregory GeneDirectorSep 15, 2020 Option Exercise$3.6713,04647,879244,530Sep 17, 2020, 04:57 PM
NEELS GUIDO JDirectorSep 03, 2020 Option Exercise$11.752,59130,4442,591Sep 08, 2020, 05:37 PM
Rudelius Robert JamesDirectorSep 03, 2020 Option Exercise$11.752,59130,44448,183Sep 08, 2020, 05:37 PM
Wendell Amy McBrideDirectorSep 03, 2020 Option Exercise$11.752,59130,44425,924Sep 08, 2020, 05:36 PM
Levine Alan MDirectorSep 03, 2020 Option Exercise$11.752,59130,4442,591Sep 08, 2020, 05:36 PM
Blackford Quentin S.DirectorSep 03, 2020 Option Exercise$11.752,59130,44418,126Sep 08, 2020, 05:36 PM
Gold Mark StephenDirectorSep 03, 2020 Option Exercise$11.752,59130,444311,862Sep 08, 2020, 11:05 AM
Blackford Quentin S.DirectorAug 12, 2019 Buy$14.1014,170199,79715,535Jun 05, 2020, 04:48 PM
Blackford Quentin S.DirectorAug 09, 2019 Buy$13.101,36517,8761,365Jun 05, 2020, 04:48 PM
Donovan Michael PatrickVP OperationsMay 28, 2020 Option Exercise$4.1615,00062,40043,646Jun 01, 2020, 07:08 AM
Freitag Gregory GeneGeneral CounselMay 29, 2020 Option Exercise$3.50125,000437,500231,484Jun 01, 2020, 07:08 AM
DeVinney Erick WayneVP, Clinical&Translational ScApr 28, 2020 Option Exercise$0.272,53068351,056Apr 29, 2020, 05:56 PM
Zaderej Karen L.CEOApr 16, 2020 Option Exercise$4.8111,62555,916658,869Apr 20, 2020, 08:17 AM
Zaderej Karen L.CEOFeb 18, 2020 Option Exercise$14.685,42979,698631,229Feb 20, 2020, 04:17 PM
Scopelianos AngeloVP Research & DevelopmentFeb 18, 2020 Option Exercise$14.683945,7842,249Feb 20, 2020, 04:17 PM
MARIANI PETER JChief Financial OfficerFeb 18, 2020 Option Exercise$14.683,25647,79820,683Feb 20, 2020, 04:16 PM
Friedman Mark LouisVP,Regulatory & QualityFeb 18, 2020 Option Exercise$14.6892413,5644,802Feb 20, 2020, 01:25 PM
Sandberg EricChief Commercial OfficerFeb 18, 2020 Option Exercise$14.6893613,7401,595Feb 20, 2020, 01:19 PM
Freitag Gregory GeneGeneral CounselFeb 18, 2020 Option Exercise$14.681,53122,475106,484Feb 20, 2020, 01:19 PM
DeVinney Erick WayneVP, Clinical&Translational ScFeb 18, 2020 Option Exercise$14.681,84927,14348,526Feb 20, 2020, 01:19 PM
Billet IsabelleChief Strategy and BD OfficerFeb 18, 2020 Option Exercise$14.684406,4596,521Feb 20, 2020, 01:18 PM
MARTINEZ MARIA D.Chief Human Resources OfficerFeb 18, 2020 Option Exercise$14.683945,7842,932Feb 20, 2020, 01:18 PM
Zaderej Karen L.CEOJan 01, 2020 Option Exercise$17.3410,112175,342622,680Jan 17, 2020, 08:41 PM
Rudelius Robert JamesDirectorJan 01, 2020 Option Exercise$17.891,99935,76245,592Jan 03, 2020, 08:03 AM
Rudelius Robert JamesDirectorJan 01, 2020 Option Exercise$2.7513,00035,75047,591Jan 03, 2020, 08:03 AM
Friedman Mark LouisVP,Regulatory & QualityDec 18, 2019 Option Exercise$16.731833,0622,127Dec 20, 2019, 04:27 PM
DeVinney Erick WayneVP, Clinical&Translational ScDec 18, 2019 Option Exercise$16.732814,70142,840Dec 20, 2019, 04:27 PM
MARIANI PETER JChief Financial OfficerDec 18, 2019 Option Exercise$16.731,04917,55012,433Dec 20, 2019, 04:27 PM
Donovan Michael PatrickVP OperationsDec 18, 2019 Option Exercise$16.731833,06226,041Dec 20, 2019, 04:16 PM
Freitag Gregory GeneGeneral CounselDec 18, 2019 Option Exercise$16.735679,486101,543Dec 20, 2019, 04:16 PM
Donovan Michael PatrickVP OperationsOct 08, 2019 Option Exercise$4.376,50028,40025,474Oct 10, 2019, 09:32 PM
Gold Mark StephenDirectorAug 09, 2019 Buy$13.104,00052,389348,761Aug 15, 2019, 04:03 PM
Billet IsabelleChief Strategy and BD OfficerAug 13, 2019 Buy$15.115,63585,1395,635Aug 14, 2019, 04:23 PM
MARTINEZ MARIA D.Chief Human Resources OfficerAug 14, 2019 Buy$15.132,00030,2602,000Aug 14, 2019, 04:23 PM
Blackford Quentin S.DirectorAug 09, 2019 Buy$13.101,36517,87625,298Aug 13, 2019, 08:45 AM
Blackford Quentin S.DirectorAug 12, 2019 Buy$14.1014,170199,79739,468Aug 13, 2019, 08:45 AM
Zaderej Karen L.CEOAug 09, 2019 Buy$13.5075,0001,012,425593,280Aug 12, 2019, 08:59 AM
Donovan Michael PatrickVP OperationsJun 13, 2019 Sale$20.0020,000400,00018,974Jun 14, 2019, 04:34 PM
Wendell Amy McBrideDirectorJun 13, 2019 Buy$20.255,000101,25023,333Jun 14, 2019, 04:31 PM
Zaderej Karen L.CEOMay 29, 2019 Option Exercise$0.2718,0564,875510,280May 31, 2019, 04:07 PM
Friedman Mark LouisVP,Regulatory & QualityMay 17, 2019 Option Exercise$21.1467,9521,436,5941,560May 17, 2019, 09:47 PM
Hansen David KVP Finance & TreasurerMay 13, 2019 Sale$22.6320,000452,60025,588May 16, 2019, 09:14 PM
Zaderej Karen L.CEOFeb 15, 2019 Option Exercise$17.5716,015281,384492,224Feb 19, 2019, 01:25 PM
Freitag Gregory GeneGeneral CounselFeb 15, 2019 Option Exercise$17.573,37759,334100,260Feb 19, 2019, 01:25 PM
MARIANI PETER JChief Financial OfficerFeb 15, 2019 Option Exercise$17.572,35541,3779,682Feb 19, 2019, 01:25 PM
Friedman Mark LouisVP,Regulatory & QualityFeb 15, 2019 Option Exercise$17.5757310,06869,512Feb 19, 2019, 01:25 PM
Hansen David KVP Finance & TreasurerFeb 15, 2019 Option Exercise$17.5757310,06845,588Feb 19, 2019, 01:24 PM
Donovan Michael PatrickVP OperationsFeb 15, 2019 Option Exercise$17.5757310,06838,974Feb 19, 2019, 01:24 PM
DeVinney Erick WayneVP, Clinical&Translational ScFeb 15, 2019 Option Exercise$17.571,49826,32041,971Feb 19, 2019, 01:24 PM
Gingrich Jon S.Chief Commercial OfficerFeb 15, 2019 Option Exercise$17.571,34223,5794,190Feb 19, 2019, 01:24 PM
Zaderej Karen L.CEONov 19, 2018 Option Exercise$2.7430,00082,200476,209Dec 21, 2018, 09:29 AM
Freitag Gregory GeneGeneral CounselNov 30, 2018 Sale$33.0045,0001,485,00095,865Dec 04, 2018, 07:30 PM
Zaderej Karen L.CEONov 19, 2018 Option Exercise$28.376,761191,810446,209Nov 21, 2018, 04:26 PM
Zaderej Karen L.CEONov 19, 2018 Option Exercise$2.7470,000191,800452,970Nov 21, 2018, 04:26 PM
DeVinney Erick WayneVP, Clinical&Translational ScNov 13, 2018 Option Exercise$33.282,88295,91337,136Nov 15, 2018, 05:18 PM
DeVinney Erick WayneVP, Clinical&Translational ScNov 13, 2018 Option Exercise$2.7235,27495,97440,018Nov 15, 2018, 05:18 PM
Freitag Gregory GeneGeneral CounselNov 15, 2018 Sale$32.2520,000645,000140,865Nov 15, 2018, 05:16 PM
Zaderej Karen L.CEONov 14, 2018 Sale$32.9312,000395,160382,970Nov 15, 2018, 05:14 PM
Zaderej Karen L.CEONov 13, 2018 Sale$33.4213,000434,460394,970Nov 15, 2018, 05:14 PM
Grooms Jamie MarkDirectorSep 20, 2018 Option Exercise$2.6512,49433,13318,693Sep 24, 2018, 04:43 PM
Wendell Amy McBrideDirectorAug 14, 2018 Buy$36.895,000184,45018,333Aug 16, 2018, 05:10 PM
MCCARREY SHAWN FSVP SalesAug 07, 2018 Option Exercise$39.305,136201,84582,921Aug 09, 2018, 04:44 PM
MCCARREY SHAWN FSVP SalesAug 07, 2018 Option Exercise$3.6755,000201,85088,057Aug 09, 2018, 04:44 PM
Zaderej Karen L.CEOAug 07, 2018 Option Exercise$39.3010,060395,358407,970Aug 09, 2018, 04:44 PM
Zaderej Karen L.CEOAug 02, 2018 Option Exercise$2.74175,000479,500418,030Aug 06, 2018, 06:00 PM
Rudelius Robert JamesDirectorJun 08, 2018 Option Exercise$48.4068233,00934,591Jun 12, 2018, 04:42 PM
Rudelius Robert JamesDirectorJun 08, 2018 Option Exercise$2.7512,00033,00035,273Jun 12, 2018, 04:42 PM
Gold Mark StephenDirectorJun 01, 2018 Option Exercise$14.8515,000222,750375,248Jun 05, 2018, 05:02 PM
MCCARREY SHAWN FSVP SalesMay 16, 2018 Sale$43.4710,000434,70033,057May 18, 2018, 06:25 PM
Donovan Michael PatrickVP OperationsMar 26, 2018 Option Exercise$40.252,04282,19137,617Mar 27, 2018, 06:45 PM
Donovan Michael PatrickVP OperationsMar 26, 2018 Option Exercise$2.7430,00082,20039,659Mar 27, 2018, 06:45 PM
Hansen David KVP Finance & TreasurerMar 22, 2018 Option Exercise$39.552,529100,02243,792Mar 26, 2018, 06:13 PM
Hansen David KVP Finance & TreasurerMar 22, 2018 Option Exercise$2.7436,500100,02544,821Mar 26, 2018, 06:13 PM
Freitag Gregory GeneGeneral Counsel & SVP BDMar 21, 2018 Option Exercise$38.502,896111,496160,865Mar 23, 2018, 08:44 AM
Freitag Gregory GeneGeneral Counsel & SVP BDMar 21, 2018 Option Exercise$3.6031,000111,510162,739Mar 23, 2018, 08:44 AM
Freitag Gregory GeneGeneral Counsel & SVP BDMar 01, 2018 Option Exercise$33.952,90598,625132,761Mar 05, 2018, 05:27 PM
Freitag Gregory GeneGeneral Counsel & SVP BDMar 01, 2018 Option Exercise$2.7436,00098,640135,666Mar 05, 2018, 05:27 PM
Grooms Jamie MarkDirectorFeb 21, 2018 Sale$28.4057,4061,630,330372Feb 23, 2018, 07:08 PM
Grooms Jamie MarkDirectorFeb 20, 2018 Sale$27.9036,7401,025,04662,861Feb 20, 2018, 07:52 PM
Grooms Jamie MarkDirectorFeb 16, 2018 Sale$27.3526,655729,01499,601Feb 20, 2018, 07:52 PM
MCCARREY SHAWN FSVP SalesFeb 16, 2018 Option Exercise$27.403,26089,32443,057Feb 20, 2018, 07:55 AM
Grooms Jamie MarkDirectorFeb 15, 2018 Sale$27.1143,4031,176,655126,256Feb 16, 2018, 08:14 PM
Grooms Jamie MarkDirectorFeb 14, 2018 Sale$26.7242,0091,122,390169,659Feb 16, 2018, 08:14 PM
Grooms Jamie MarkDirectorFeb 13, 2018 Sale$26.2110,300269,924202,595Feb 16, 2018, 08:14 PM
Grooms Jamie MarkVP, CFOFeb 15, 2018 Sale$27.1143,4031,176,655126,256Feb 15, 2018, 07:56 PM
Grooms Jamie MarkVP, CFOFeb 14, 2018 Sale$26.7242,0091,122,390169,659Feb 15, 2018, 07:56 PM
Grooms Jamie MarkVP, CFOFeb 13, 2018 Sale$26.2110,300269,924202,595Feb 15, 2018, 07:56 PM
Grooms Jamie MarkDirectorDec 12, 2017 Sale$26.3416,585436,849240,607Dec 13, 2017, 07:45 PM
Grooms Jamie MarkDirectorDec 11, 2017 Sale$26.3521,820574,957257,192Dec 13, 2017, 07:45 PM
Grooms Jamie MarkDirectorDec 08, 2017 Sale$26.3731,805838,698279,012Dec 13, 2017, 07:44 PM
Grooms Jamie MarkDirectorDec 07, 2017 Sale$26.4733,500886,745310,817Dec 13, 2017, 07:44 PM
Grooms Jamie MarkDirectorDec 06, 2017 Sale$26.2221,290558,224344,317Dec 13, 2017, 07:44 PM
Grooms Jamie MarkDirectorDec 06, 2017 Sale$26.2221,290558,224344,317Dec 08, 2017, 06:30 PM
Grooms Jamie MarkDirectorDec 08, 2017 Sale$26.3731,805838,698281,312Dec 08, 2017, 06:30 PM
Grooms Jamie MarkDirectorDec 07, 2017 Sale$26.5031,200826,800313,117Dec 08, 2017, 06:30 PM
Essex Woodlands Fund IX, L.P.10% OwnerNov 20, 2017 Sale$19.741,150,00022,701,0003,711,111Nov 21, 2017, 03:31 PM
NEELS GUIDO JDirectorNov 20, 2017 Sale$19.741,150,00022,701,0003,371,111Nov 21, 2017, 03:31 PM
Gold Mark StephenDirectorNov 13, 2017 Option Exercise$5.0915,00076,350360,248Nov 15, 2017, 11:22 AM
Grooms Jamie MarkDirectorNov 01, 2017 Option Exercise$20.601893,893365,607Nov 03, 2017, 04:56 PM
Grooms Jamie MarkDirectorNov 01, 2017 Option Exercise$0.2714,3793,882365,796Nov 03, 2017, 04:56 PM
Friedman Mark LouisVP,Regulatory & QualityOct 24, 2017 Option Exercise$20.005,480109,60040,185Oct 26, 2017, 05:04 PM
Friedman Mark LouisVP,Regulatory & QualityOct 24, 2017 Option Exercise$2.5867,767174,96267,952Oct 26, 2017, 05:04 PM
Freitag Gregory GeneGeneral Counsel & SVP BDSep 25, 2017 Option Exercise$18.901,45027,40599,666Sep 27, 2017, 05:22 PM
Freitag Gregory GeneGeneral Counsel & SVP BDSep 25, 2017 Option Exercise$2.7410,00027,400101,116Sep 27, 2017, 05:22 PM
Rudelius Robert JamesDirectorSep 08, 2017 Option Exercise$18.153,85770,00539,416Sep 12, 2017, 04:02 PM
Rudelius Robert JamesDirectorSep 08, 2017 Option Exercise$3.5020,00070,00043,273Sep 12, 2017, 04:02 PM
Rudelius Robert JamesDirectorSep 11, 2017 Sale$18.0016,143290,57423,273Sep 12, 2017, 04:02 PM
Freitag Gregory GeneGeneral Counsel & SVP BDAug 27, 2017 Option Exercise$16.653,78563,02091,116Aug 29, 2017, 04:58 PM
Freitag Gregory GeneGeneral Counsel & SVP BDAug 27, 2017 Option Exercise$2.7423,00063,02094,901Aug 29, 2017, 04:58 PM
MCCARREY SHAWN FSVP SalesAug 02, 2017 Option Exercise$15.152,38336,10239,167Aug 04, 2017, 05:10 PM
Gold Mark StephenDirectorMay 30, 2017 Option Exercise$8.955,00044,750345,248Jun 01, 2017, 01:51 PM
Gold Mark StephenDirectorMay 22, 2017 Option Exercise$4.8115,00072,150340,248May 26, 2017, 04:24 PM
DeVinney Erick WayneVP, Clinical&Translational ScMar 14, 2017 Option Exercise$0.275,0181,3555,018Mar 14, 2017, 07:32 PM
Donovan Michael PatrickVP OperationsMar 14, 2017 Option Exercise$1.559,65914,9589,659Mar 14, 2017, 07:32 PM
Freitag Gregory GeneGeneral Counsel & SVP BDDec 30, 2016 Option Exercise$2.7423,00063,02071,901Mar 14, 2017, 07:31 PM
Wendell Amy McBrideDirectorOct 07, 2016 Buy$7.5013,33399,99813,333Oct 14, 2016, 03:36 PM
Leach KevinVice President MarketingOct 07, 2016 Buy$7.502,00015,0002,000Oct 14, 2016, 03:14 PM
MARIANI PETER JChief Financial OfficerOct 07, 2016 Buy$7.503,33324,9983,333Oct 14, 2016, 03:13 PM
Zaderej Karen L.CEOOct 07, 2016 Buy$7.5010,00075,000242,147Oct 14, 2016, 01:37 PM
Engels John PVPOct 07, 2016 Buy$7.504,00030,00098,425Oct 14, 2016, 01:37 PM
Gold Mark StephenDirectorAug 17, 2016 Option Exercise$3.603,75013,500325,248Aug 19, 2016, 03:25 PM
Mandato Joseph MDirectorAug 09, 2016 Sale$8.3042,168349,9941,226,773Aug 10, 2016, 07:28 PM
Mandato Joseph MDirectorAug 08, 2016 Sale$8.63107,450927,2941,268,941Aug 10, 2016, 07:28 PM
Flynn James E10% OwnerJul 21, 2016 Sale$6.70102,136684,3113,000,000Jul 21, 2016, 04:26 PM
Flynn James E10% OwnerJul 14, 2016 Sale$7.70206,0901,586,8933,175,349Jul 18, 2016, 06:20 PM
Flynn James E10% OwnerJul 18, 2016 Sale$6.8741,425284,5903,102,136Jul 18, 2016, 06:20 PM
Flynn James E10% OwnerJul 15, 2016 Sale$7.3231,788232,6883,143,561Jul 18, 2016, 06:20 PM
Hansen David KChief Accounting OfficerMay 31, 2016 Option Exercise$0.279,8212,6529,821Jun 01, 2016, 05:00 PM
Gold Mark StephenDirectorNov 12, 2015 Option Exercise$3.6011,25040,500321,498Nov 12, 2015, 06:55 PM
Gold Mark StephenDirectorNov 06, 2015 Sale$5.706,01334,274310,248Nov 12, 2015, 09:24 AM
Flynn James E10% OwnerSep 18, 2015 Sale$5.50345,0001,897,9833,381,439Sep 22, 2015, 01:05 PM
Gold Mark StephenDirectorSep 08, 2015 Option Exercise$2.7513,00035,750316,261Sep 10, 2015, 03:41 PM
Mandato Joseph MDirectorJun 03, 2015 Buy$3.106,50020,15050,000Jun 05, 2015, 03:14 PM
Johnston Lee Robert JrChief Finacial OfficerJun 02, 2015 Buy$3.065,00015,30325,000Jun 03, 2015, 04:46 PM
Zaderej Karen L.Chief Executive OfficerMay 27, 2015 Buy$3.163,32510,493232,147May 29, 2015, 02:58 PM
Flynn James E10% OwnerApr 08, 2015 Sale$3.25144,385469,2513,726,439Apr 09, 2015, 01:55 PM
Gold Mark StephenDirectorSep 30, 2014 Option Exercise$1.07290310303,261Mar 12, 2015, 09:21 AM
Zaderej Karen L.Chief Executive OfficerFeb 10, 2015 Option Exercise$2.759,60026,400228,822Feb 12, 2015, 03:44 PM
Freitag Gregory GeneGeneral CounselFeb 10, 2015 Option Exercise$2.754,80013,20048,902Feb 12, 2015, 03:44 PM
MCCARREY SHAWN FSVP of SalesFeb 10, 2015 Option Exercise$2.754,40012,10034,400Feb 12, 2015, 03:43 PM
Mandato Joseph MDirectorDec 11, 2014 Sale$3.152,3427,3771,376,392Jan 06, 2015, 06:25 PM
Mandato Joseph MDirectorDec 10, 2014 Sale$3.0647,658145,7141,378,734Jan 06, 2015, 06:25 PM
Johnston Lee Robert JrChief Financial OfficerDec 10, 2014 Buy$3.0610,00030,60010,000Dec 11, 2014, 03:39 PM
Mandato Joseph MDirectorDec 01, 2014 Option Exercise$2.946,00017,64043,500Dec 03, 2014, 09:57 PM
Gold Mark StephenDirectorSep 30, 2014 Option Exercise$1.07290310303,261Oct 02, 2014, 06:08 PM
Gold Mark StephenDirectorAug 12, 2014 Buy$2.2920,00045,800302,971Aug 15, 2014, 07:44 AM
Mandato Joseph MDirectorAug 08, 2014 Option Exercise$2.307,50017,27537,500Aug 12, 2014, 05:00 PM
Gold Mark StephenDirectorAug 08, 2014 Buy$2.3111,00025,410282,971Aug 11, 2014, 01:15 PM
Johnston Lee Robert JrChief Financial OfficerJun 06, 2014 Buy$2.5810,00025,75710,000Jun 10, 2014, 05:15 PM
Zaderej Karen L.Chief Executive OfficerJun 03, 2014 Buy$2.435,00012,150334,056Jun 04, 2014, 03:54 PM
Freitag Gregory GeneCFOJun 03, 2014 Buy$2.3420046829,518Jun 04, 2014, 03:53 PM
Freitag Gregory GeneCFOJun 02, 2014 Buy$2.455,00012,25029,318Jun 04, 2014, 03:53 PM
Schiaparelli Jill FSVP, Bus. Strategy&MarketingMay 20, 2014 Buy$2.632,0005,26012,750May 22, 2014, 05:56 PM
Zaderej Karen L.Chief Executive OfficerMay 12, 2014 Buy$2.705,00013,500329,056May 13, 2014, 10:55 AM
Mandato Joseph MDirectorMay 05, 2014 Option Exercise$2.6415,00039,60030,000May 12, 2014, 12:33 PM
Gold Mark StephenDirectorMay 07, 2014 Buy$2.601,4873,866271,971May 08, 2014, 05:20 PM
Gold Mark StephenDirectorMay 06, 2014 Buy$2.604901,274270,484May 08, 2014, 05:20 PM
Gold Mark StephenDirectorApr 25, 2014 Option Exercise$2.0217,00734,352269,994Apr 28, 2014, 05:35 PM
Zaderej Karen L.Chief Executive OfficerMar 14, 2014 Option Exercise$0.2772,34819,534209,222Mar 17, 2014, 07:34 PM
Zaderej Karen L.Chief Executive OfficerMar 13, 2014 Buy$3.491,5005,233136,874Mar 17, 2014, 07:34 PM
Gold Mark StephenDirectorNov 19, 2013 Option Exercise$1.07290311252,987Nov 19, 2013, 02:43 PM
MCCARREY SHAWN FSVP of SalesAug 29, 2013 Buy$3.2112,62540,52630,000Aug 30, 2013, 01:47 PM
MCCARREY SHAWN FSVP of SalesAug 28, 2013 Buy$3.2012,37539,62517,375Aug 30, 2013, 01:47 PM
MCCARREY SHAWN FSVP of SalesAug 24, 2013 Buy$3.005,00015,0005,000Aug 27, 2013, 01:24 PM
Mandato Joseph MDirectorAug 19, 2013 Option Exercise$3.0010,00030,00015,000Aug 20, 2013, 06:19 PM
Mandato Joseph MDirectorAug 16, 2013 Option Exercise$2.995,00014,9505,000Aug 20, 2013, 06:19 PM
Schiaparelli Jill FSVP, Bus. Strategy&MarketingAug 14, 2013 Buy$3.005,00015,00010,750Aug 16, 2013, 02:48 PM
Harper John FrederickDirectorAug 14, 2013 Buy$3.0066,666199,998214,094Aug 15, 2013, 03:45 PM
Zaderej Karen L.Chief Executive OfficerAug 14, 2013 Buy$3.008,33425,002129,124Aug 15, 2013, 03:18 PM
Freitag Gregory GeneCFOAug 14, 2013 Buy$3.008,33425,00232,652Aug 15, 2013, 03:07 PM
Harper John FrederickDirectorOct 01, 2012 Buy$3.6186,557312,471147,428Apr 10, 2013, 04:34 PM
Gold Mark StephenDirectorFeb 25, 2013 Option Exercise$0.315,2961,66219,484Feb 28, 2013, 02:32 PM
Gold Mark StephenDirectorMay 10, 2012 Option Exercise$0.278,7332,35814,188Feb 28, 2013, 02:32 PM
Zaderej Karen L.Chief Executive OfficerDec 10, 2012 Buy$2.509002,250120,790Dec 13, 2012, 01:25 PM
Schiaparelli Jill FSVP, Bus. Strategy&MarketingDec 04, 2012 Buy$2.552,0005,1005,750Dec 06, 2012, 08:20 AM
Schiaparelli Jill FSVP, Bus. Strategy&MarketingNov 29, 2012 Buy$2.701,0002,7003,750Dec 03, 2012, 04:08 PM
Zaderej Karen L.Chief Executive OfficerNov 20, 2012 Buy$2.69100269119,890Nov 23, 2012, 09:18 AM
Schiaparelli Jill FSVP, Bus. Strategy&MarketingNov 15, 2012 Buy$2.522,0005,0401,000Nov 16, 2012, 03:26 PM
Schiaparelli Jill FSVP, Bus. Strategy&MarketingNov 14, 2012 Buy$2.667501,995750Nov 16, 2012, 03:26 PM
Mandato Joseph MDirectorOct 10, 2011 Option Exercise$2.755,45515,0011,431,847Feb 13, 2012, 02:14 PM
Friedman Mark LouisVice President of RA/QADec 23, 2011 Option Exercise$0.275,6651,5305,665Jan 24, 2012, 04:08 PM
Rudelius Robert JamesDirectorDec 30, 2011 Option Exercise$2.409,31822,36323,273Jan 03, 2012, 03:50 PM
Freitag Gregory GeneCFODec 30, 2011 Buy$2.409,31822,36324,318Jan 03, 2012, 03:49 PM
Zaderej Karen L.Chief Executive OfficerDec 19, 2011 Option Exercise$0.2776,74120,720119,790Dec 21, 2011, 08:18 PM
Rudelius Robert JamesDirectorNov 05, 2011 Buy$2.703,5009,45013,955Dec 06, 2011, 07:51 AM
Rudelius Robert JamesDirectorNov 02, 2011 Buy$2.744,50012,32510,455Dec 06, 2011, 07:51 AM
Rudelius Robert JamesDirectorNov 01, 2011 Buy$2.705001,3505,955Dec 06, 2011, 07:51 AM
Freitag Gregory GeneCFONov 22, 2011 Buy$2.929,00026,25015,000Nov 23, 2011, 02:36 PM
Freitag Gregory GeneCFONov 21, 2011 Buy$2.906,00017,3956,000Nov 23, 2011, 02:36 PM
Grooms Jamie MarkDirectorOct 10, 2011 Option Exercise$2.755,45515,001218,534Oct 12, 2011, 05:35 PM
Rudelius Robert JamesDirectorOct 10, 2011 Option Exercise$2.755,45515,0015,455Oct 12, 2011, 05:33 PM
Harper John FrederickDirectorOct 10, 2011 Option Exercise$2.755,45515,00151,553Oct 12, 2011, 05:31 PM
Mandato Joseph MDirectorOct 10, 2011 Option Exercise$2.755,45515,0015,455Oct 12, 2011, 05:27 PM
Gold Mark StephenDirectorOct 10, 2011 Option Exercise$2.755,45515,0015,455Oct 12, 2011, 05:25 PM
Hopfenspirger Larry10% OwnerSep 28, 2011 Buy$1.8120,00036,200426,066Sep 28, 2011, 05:29 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Zaderej Karen L.CEO03/21/2024301,670
DeVinney Erick WayneChief Innovation Officer03/21/202435,159
Scopelianos AngeloChief R&D Officer03/21/202452,846
Donovan Michael PatrickVP Operations03/21/202446,333
Donovan Michael PatrickVP Operations03/07/2024319,891
Freitag Gregory GeneDirector03/07/2024225,000
MARIANI PETER JEVP & Chief Financial Officer12/11/202393,809
MARIANI PETER JEVP & Chief Financial Officer10/13/202313,183
DeVinney Erick WayneVP Peripheral Nerve Science10/13/20233,491
Donovan Michael PatrickVP Operations10/13/20235,668
Scopelianos AngeloChief R&D Officer10/13/20235,668
MARTINEZ MARIA D.Chief Human Resources Officer10/13/20235,668
Wendell Amy McBrideDirector09/06/202362,240
Burke William P. Mr.Director08/24/202337,860
Burke William P. Mr.Director08/23/202365,600
NEELS GUIDO JDirector08/16/202361,100
Freitag Gregory GeneDirector06/01/2023365,780
Freitag Gregory GeneDirector05/23/202368,899
Wendell Amy McBrideDirector05/12/2023265,075
MARTINEZ MARIA D.Chief Human Resources Officer03/16/202335,313
Donovan Michael PatrickVP Operations03/16/202322,900
DeVinney Erick WayneVP Peripheral Nerve Science03/16/202322,900
Ottinger BradleyGeneral Counsel and CCO03/16/202321,783
Scopelianos AngeloChief R&D Officer03/16/202332,311
MARIANI PETER JEVP & Chief Financial Officer03/16/202358,204
MARIANI PETER JEVP & Chief Financial Officer02/01/2023105,538
MARIANI PETER JEVP & Chief Financial Officer01/31/2023105,533
MARIANI PETER JEVP & Chief Financial Officer01/30/2023105,533
MARIANI PETER JEVP & Chief Financial Officer02/01/2023136,188
MARIANI PETER JEVP & Chief Financial Officer01/31/2023136,756
MARIANI PETER JEVP & Chief Financial Officer01/30/2023136,736
MARIANI PETER JEVP & Chief Financial Officer01/27/2023105,538
MARIANI PETER JEVP & Chief Financial Officer01/26/2023105,533
MARIANI PETER JEVP & Chief Financial Officer01/25/2023105,533
MARIANI PETER JEVP & Chief Financial Officer01/27/2023212,750
MARIANI PETER JEVP & Chief Financial Officer01/26/2023207,296
MARIANI PETER JEVP & Chief Financial Officer01/25/2023214,206
Donovan Michael PatrickVP Operations12/27/20222,700
DeVinney Erick WayneVP Peripheral Nerve Science12/27/20221,765
Billet IsabelleChief Strategy and BD Officer12/27/20223,087
MARIANI PETER JEVP & Chief Financial Officer12/27/20226,127
MARTINEZ MARIA D.Chief Human Resources Officer12/27/20222,700
Scopelianos AngeloChief R&D Officer12/27/20222,700
DeVinney Erick WayneVP Peripheral Nerve Science12/27/2022101,801
DeVinney Erick WayneVP Peripheral Nerve Science12/27/2022101,800
Zaderej Karen L.CEO12/15/2022136,137
MARIANI PETER JEVP & Chief Financial Officer12/14/202297,605
MARIANI PETER JEVP & Chief Financial Officer12/14/202297,595
MARIANI PETER JEVP & Chief Financial Officer11/16/2022126,510
Freitag Gregory GeneDirector11/14/2022165,620
Freitag Gregory GeneDirector11/08/2022162,500
Freitag Gregory GeneDirector08/10/202286,159
Freitag Gregory GeneDirector08/08/2022135,287
Freitag Gregory GeneDirector08/04/2022255,360
Freitag Gregory GeneDirector07/25/2022280,541
Freitag Gregory GeneDirector07/25/2022280,540
Sandberg EricChief Commercial Officer07/19/20229,450
Scopelianos AngeloChief R&D Officer07/19/20225,519
DeVinney Erick WayneVP Peripheral Nerve Science07/19/20223,402
Billet IsabelleChief Strategy and BD Officer07/19/20226,308
Donovan Michael PatrickVP Operations07/19/20225,519
Zaderej Karen L.CEO07/19/202276,280
MARIANI PETER JEVP & Chief Financial Officer07/19/20227,955
MARTINEZ MARIA D.Chief Human Resources Officer07/19/20225,519
MARTINEZ MARIA D.Chief Human Resources Officer03/16/202225,815
Scopelianos AngeloChief R&D Officer03/16/202222,077
Sandberg EricChief Commercial Officer03/16/202212,051
Ottinger BradleyGeneral Counsel and CCO03/16/20225,165
MARIANI PETER JEVP & Chief Financial Officer03/16/202222,069
Friedman Mark LouisVP Regulatory Affairs & Policy03/16/202211,971
Donovan Michael PatrickVP Operations03/16/202212,051
DeVinney Erick WayneVP Peripheral Nerve Science03/16/202211,931
Billet IsabelleChief Strategy and BD Officer03/16/202219,503
Donovan Michael PatrickVP Operations02/22/202278,150
Sandberg EricChief Commercial Officer02/15/20226,416
Scopelianos AngeloChief R&D Officer02/15/20223,368
MARTINEZ MARIA D.Chief Human Resources Officer02/15/20223,368
DeVinney Erick WayneVP Peripheral Nerve Science02/15/20223,006
Billet IsabelleChief Strategy and BD Officer02/15/20223,764
Zaderej Karen L.CEO12/27/202117,064
Scopelianos AngeloChief R&D Officer12/27/20212,786
MARTINEZ MARIA D.Chief Human Resources Officer12/27/20212,786
MARIANI PETER JEVP & Chief Financial Officer12/27/20216,312
Friedman Mark LouisVP Regulatory Affairs & Policy12/27/20212,786
Donovan Michael PatrickVP Operations12/27/20212,786
DeVinney Erick WayneVP Peripheral Nerve Science12/27/20211,821
Billet IsabelleChief Strategy and BD Officer12/27/20213,175
Zaderej Karen L.CEO12/20/202111,485
MARIANI PETER JEVP & Chief Financial Officer12/20/20216,995
Friedman Mark LouisVP Regulatory Affairs & Policy12/20/2021878
Donovan Michael PatrickVP Operations12/20/2021878
DeVinney Erick WayneVP Peripheral Nerve Science12/20/20211,331
DeVinney Erick WayneVP Peripheral Nerve Science12/15/202136,705
DeVinney Erick WayneVP Peripheral Nerve Science12/15/202136,700
Zaderej Karen L.CEO11/24/2021468,756
Zaderej Karen L.CEO08/13/2021170,655
Zaderej Karen L.CEO08/12/202142,013
Zaderej Karen L.CEO08/10/2021381,750
Zaderej Karen L.CEO08/06/2021757,194
Donovan Michael PatrickVP Operations07/21/202138,777
DeVinney Erick WayneVP Peripheral Nerve Science07/20/20217,526
Donovan Michael PatrickVP Operations07/20/202112,230
Zaderej Karen L.CEO07/20/2021169,190
Sandberg EricChief Commercial Officer07/20/202120,928
Scopelianos AngeloChief R&D Officer07/20/202112,230
MARIANI PETER JEVP & Chief Financial Officer07/20/202117,626
Billet IsabelleChief Strategy and BD Officer07/20/202113,978
MARTINEZ MARIA D.Chief Human Resources Officer07/20/202112,230
Friedman Mark LouisVP Regulatory Affairs & Policy07/20/202112,230
NEELS GUIDO JDirector05/19/2021171,350
DeVinney Erick WayneVP of Clin. & Trans. Sciences04/28/202128,600
Zaderej Karen L.CEO04/16/2021509,000
Zaderej Karen L.CEO03/25/2021126,615
Freitag Gregory GeneDirector02/25/2021529,440
Donovan Michael PatrickVP Operations02/18/202134,623
Scopelianos AngeloChief R&D Officer02/17/20217,596
Friedman Mark LouisVP, Regulatory & Quality02/17/202117,787
DeVinney Erick WayneVP, Clinical&Translational Sc02/17/202134,857
Sandberg EricChief Commercial Officer02/17/202116,886
Donovan Michael PatrickVP Operations02/17/202114,912
Freitag Gregory GeneDirector02/17/202129,490
MARTINEZ MARIA D.Chief Human Resources Officer02/17/20217,596
MARIANI PETER JChief Financial Officer02/17/202155,261
Zaderej Karen L.CEO02/17/2021143,805
Billet IsabelleChief Strategy and BD Officer02/17/20218,494
Donovan Michael PatrickVP Operations02/05/2021102,814
Donovan Michael PatrickVP Operations02/05/2021102,800
Zaderej Karen L.CEO01/08/20211,300,000
Donovan Michael PatrickVP Operations12/30/202030,293
DeVinney Erick WayneVP, Clinical&Translational Sc12/29/20206,608
Donovan Michael PatrickVP Operations12/29/202010,098
Freitag Gregory GeneDirector12/29/202016,314
MARIANI PETER JChief Financial Officer12/29/202023,028
Scopelianos AngeloVP Research & Development12/29/202010,098
Zaderej Karen L.CEO12/29/202062,335
Friedman Mark LouisVP,Regulatory & Quality12/29/202010,098
MARTINEZ MARIA D.Chief Human Resources Officer12/29/202010,098
Billet IsabelleChief Strategy and BD Officer12/29/202011,559
Zaderej Karen L.CEO12/23/202093,194
Donovan Michael PatrickVP Operations12/22/20204,796
Zaderej Karen L.CEO12/21/202020,936
DeVinney Erick WayneVP, Clinical&Translational Sc12/21/20202,414
Freitag Gregory GeneDirector12/21/20206,223
Donovan Michael PatrickVP Operations12/21/20201,576
MARIANI PETER JChief Financial Officer12/21/20207,898
Friedman Mark LouisVP,Regulatory & Quality12/21/20201,576
DeVinney Erick WayneVP, Clinical&Translational Sc12/15/202072,155
DeVinney Erick WayneVP, Clinical&Translational Sc12/15/202072,150
Friedman Mark LouisVP,Regulatory & Quality12/03/202014,703
Donovan Michael PatrickVP Operations11/09/2020264,255
Zaderej Karen L.CEO11/09/2020203,420
MARIANI PETER JChief Financial Officer10/30/2020302,400
MARIANI PETER JChief Financial Officer10/30/2020939,353
Freitag Gregory GeneDirector09/15/202047,879
NEELS GUIDO JDirector09/03/202030,444
Rudelius Robert JamesDirector09/03/202030,444
Wendell Amy McBrideDirector09/03/202030,444
Levine Alan MDirector09/03/202030,444
Blackford Quentin S.Director09/03/202030,444
Gold Mark StephenDirector09/03/202030,444
Blackford Quentin S.Director08/12/2019199,797
Blackford Quentin S.Director08/09/201917,876
Donovan Michael PatrickVP Operations05/28/202062,400
Freitag Gregory GeneGeneral Counsel05/29/2020437,500
DeVinney Erick WayneVP, Clinical&Translational Sc04/28/2020683
Zaderej Karen L.CEO04/16/202055,916
Zaderej Karen L.CEO02/18/202079,698
Scopelianos AngeloVP Research & Development02/18/20205,784
MARIANI PETER JChief Financial Officer02/18/202047,798
Friedman Mark LouisVP,Regulatory & Quality02/18/202013,564
Sandberg EricChief Commercial Officer02/18/202013,740
Freitag Gregory GeneGeneral Counsel02/18/202022,475
DeVinney Erick WayneVP, Clinical&Translational Sc02/18/202027,143
Billet IsabelleChief Strategy and BD Officer02/18/20206,459
MARTINEZ MARIA D.Chief Human Resources Officer02/18/20205,784
Zaderej Karen L.CEO01/01/2020175,342
Rudelius Robert JamesDirector01/01/202035,762
Rudelius Robert JamesDirector01/01/202035,750
Friedman Mark LouisVP,Regulatory & Quality12/18/20193,062
DeVinney Erick WayneVP, Clinical&Translational Sc12/18/20194,701
MARIANI PETER JChief Financial Officer12/18/201917,550
Donovan Michael PatrickVP Operations12/18/20193,062
Freitag Gregory GeneGeneral Counsel12/18/20199,486
Donovan Michael PatrickVP Operations10/08/201928,400
Gold Mark StephenDirector08/09/201952,389
Billet IsabelleChief Strategy and BD Officer08/13/201985,139
MARTINEZ MARIA D.Chief Human Resources Officer08/14/201930,260
Blackford Quentin S.Director08/09/201917,876
Blackford Quentin S.Director08/12/2019199,797
Zaderej Karen L.CEO08/09/20191,012,425
Donovan Michael PatrickVP Operations06/13/2019400,000
Wendell Amy McBrideDirector06/13/2019101,250
Zaderej Karen L.CEO05/29/20194,875
Friedman Mark LouisVP,Regulatory & Quality05/17/20191,436,594
Hansen David KVP Finance & Treasurer05/13/2019452,600
Zaderej Karen L.CEO02/15/2019281,384
Freitag Gregory GeneGeneral Counsel02/15/201959,334
MARIANI PETER JChief Financial Officer02/15/201941,377
Friedman Mark LouisVP,Regulatory & Quality02/15/201910,068
Hansen David KVP Finance & Treasurer02/15/201910,068
Donovan Michael PatrickVP Operations02/15/201910,068
DeVinney Erick WayneVP, Clinical&Translational Sc02/15/201926,320
Gingrich Jon S.Chief Commercial Officer02/15/201923,579
Zaderej Karen L.CEO11/19/201882,200
Freitag Gregory GeneGeneral Counsel11/30/20181,485,000
Zaderej Karen L.CEO11/19/2018191,810
Zaderej Karen L.CEO11/19/2018191,800
DeVinney Erick WayneVP, Clinical&Translational Sc11/13/201895,913
DeVinney Erick WayneVP, Clinical&Translational Sc11/13/201895,974
Freitag Gregory GeneGeneral Counsel11/15/2018645,000
Zaderej Karen L.CEO11/14/2018395,160
Zaderej Karen L.CEO11/13/2018434,460
Grooms Jamie MarkDirector09/20/201833,133
Wendell Amy McBrideDirector08/14/2018184,450
MCCARREY SHAWN FSVP Sales08/07/2018201,845
MCCARREY SHAWN FSVP Sales08/07/2018201,850
Zaderej Karen L.CEO08/07/2018395,358
Zaderej Karen L.CEO08/02/2018479,500
Rudelius Robert JamesDirector06/08/201833,009
Rudelius Robert JamesDirector06/08/201833,000
Gold Mark StephenDirector06/01/2018222,750
MCCARREY SHAWN FSVP Sales05/16/2018434,700
Donovan Michael PatrickVP Operations03/26/201882,191
Donovan Michael PatrickVP Operations03/26/201882,200
Hansen David KVP Finance & Treasurer03/22/2018100,022
Hansen David KVP Finance & Treasurer03/22/2018100,025
Freitag Gregory GeneGeneral Counsel & SVP BD03/21/2018111,496
Freitag Gregory GeneGeneral Counsel & SVP BD03/21/2018111,510
Freitag Gregory GeneGeneral Counsel & SVP BD03/01/201898,625
Freitag Gregory GeneGeneral Counsel & SVP BD03/01/201898,640
Grooms Jamie MarkDirector02/21/20181,630,330
Grooms Jamie MarkDirector02/20/20181,025,046
Grooms Jamie MarkDirector02/16/2018729,014
MCCARREY SHAWN FSVP Sales02/16/201889,324
Grooms Jamie MarkDirector02/15/20181,176,655
Grooms Jamie MarkDirector02/14/20181,122,390
Grooms Jamie MarkDirector02/13/2018269,924
Grooms Jamie MarkVP, CFO02/15/20181,176,655
Grooms Jamie MarkVP, CFO02/14/20181,122,390
Grooms Jamie MarkVP, CFO02/13/2018269,924
Grooms Jamie MarkDirector12/12/2017436,849
Grooms Jamie MarkDirector12/11/2017574,957
Grooms Jamie MarkDirector12/08/2017838,698
Grooms Jamie MarkDirector12/07/2017886,745
Grooms Jamie MarkDirector12/06/2017558,224
Grooms Jamie MarkDirector12/06/2017558,224
Grooms Jamie MarkDirector12/08/2017838,698
Grooms Jamie MarkDirector12/07/2017826,800
Essex Woodlands Fund IX, L.P.10% Owner11/20/201722,701,000
NEELS GUIDO JDirector11/20/201722,701,000
Gold Mark StephenDirector11/13/201776,350
Grooms Jamie MarkDirector11/01/20173,893
Grooms Jamie MarkDirector11/01/20173,882
Friedman Mark LouisVP,Regulatory & Quality10/24/2017109,600
Friedman Mark LouisVP,Regulatory & Quality10/24/2017174,962
Freitag Gregory GeneGeneral Counsel & SVP BD09/25/201727,405
Freitag Gregory GeneGeneral Counsel & SVP BD09/25/201727,400
Rudelius Robert JamesDirector09/08/201770,005
Rudelius Robert JamesDirector09/08/201770,000
Rudelius Robert JamesDirector09/11/2017290,574
Freitag Gregory GeneGeneral Counsel & SVP BD08/27/201763,020
Freitag Gregory GeneGeneral Counsel & SVP BD08/27/201763,020
MCCARREY SHAWN FSVP Sales08/02/201736,102
Gold Mark StephenDirector05/30/201744,750
Gold Mark StephenDirector05/22/201772,150
DeVinney Erick WayneVP, Clinical&Translational Sc03/14/20171,355
Donovan Michael PatrickVP Operations03/14/201714,958
Freitag Gregory GeneGeneral Counsel & SVP BD12/30/201663,020
Wendell Amy McBrideDirector10/07/201699,998
Leach KevinVice President Marketing10/07/201615,000
MARIANI PETER JChief Financial Officer10/07/201624,998
Zaderej Karen L.CEO10/07/201675,000
Engels John PVP10/07/201630,000
Gold Mark StephenDirector08/17/201613,500
Mandato Joseph MDirector08/09/2016349,994
Mandato Joseph MDirector08/08/2016927,294
Flynn James E10% Owner07/21/2016684,311
Flynn James E10% Owner07/14/20161,586,893
Flynn James E10% Owner07/18/2016284,590
Flynn James E10% Owner07/15/2016232,688
Hansen David KChief Accounting Officer05/31/20162,652
Gold Mark StephenDirector11/12/201540,500
Gold Mark StephenDirector11/06/201534,274
Flynn James E10% Owner09/18/20151,897,983
Gold Mark StephenDirector09/08/201535,750
Mandato Joseph MDirector06/03/201520,150
Johnston Lee Robert JrChief Finacial Officer06/02/201515,303
Zaderej Karen L.Chief Executive Officer05/27/201510,493
Flynn James E10% Owner04/08/2015469,251
Gold Mark StephenDirector09/30/2014310
Zaderej Karen L.Chief Executive Officer02/10/201526,400
Freitag Gregory GeneGeneral Counsel02/10/201513,200
MCCARREY SHAWN FSVP of Sales02/10/201512,100
Mandato Joseph MDirector12/11/20147,377
Mandato Joseph MDirector12/10/2014145,714
Johnston Lee Robert JrChief Financial Officer12/10/201430,600
Mandato Joseph MDirector12/01/201417,640
Gold Mark StephenDirector09/30/2014310
Gold Mark StephenDirector08/12/201445,800
Mandato Joseph MDirector08/08/201417,275
Gold Mark StephenDirector08/08/201425,410
Johnston Lee Robert JrChief Financial Officer06/06/201425,757
Zaderej Karen L.Chief Executive Officer06/03/201412,150
Freitag Gregory GeneCFO06/03/2014468
Freitag Gregory GeneCFO06/02/201412,250
Schiaparelli Jill FSVP, Bus. Strategy&Marketing05/20/20145,260
Zaderej Karen L.Chief Executive Officer05/12/201413,500
Mandato Joseph MDirector05/05/201439,600
Gold Mark StephenDirector05/07/20143,866
Gold Mark StephenDirector05/06/20141,274
Gold Mark StephenDirector04/25/201434,352
Zaderej Karen L.Chief Executive Officer03/14/201419,534
Zaderej Karen L.Chief Executive Officer03/13/20145,233
Gold Mark StephenDirector11/19/2013311
MCCARREY SHAWN FSVP of Sales08/29/201340,526
MCCARREY SHAWN FSVP of Sales08/28/201339,625
MCCARREY SHAWN FSVP of Sales08/24/201315,000
Mandato Joseph MDirector08/19/201330,000
Mandato Joseph MDirector08/16/201314,950
Schiaparelli Jill FSVP, Bus. Strategy&Marketing08/14/201315,000
Harper John FrederickDirector08/14/2013199,998
Zaderej Karen L.Chief Executive Officer08/14/201325,002
Freitag Gregory GeneCFO08/14/201325,002
Harper John FrederickDirector10/01/2012312,471
Gold Mark StephenDirector02/25/20131,662
Gold Mark StephenDirector05/10/20122,358
Zaderej Karen L.Chief Executive Officer12/10/20122,250
Schiaparelli Jill FSVP, Bus. Strategy&Marketing12/04/20125,100
Schiaparelli Jill FSVP, Bus. Strategy&Marketing11/29/20122,700
Zaderej Karen L.Chief Executive Officer11/20/2012269
Schiaparelli Jill FSVP, Bus. Strategy&Marketing11/15/20125,040
Schiaparelli Jill FSVP, Bus. Strategy&Marketing11/14/20121,995
Mandato Joseph MDirector10/10/201115,001
Friedman Mark LouisVice President of RA/QA12/23/20111,530
Rudelius Robert JamesDirector12/30/201122,363
Freitag Gregory GeneCFO12/30/201122,363
Zaderej Karen L.Chief Executive Officer12/19/201120,720
Rudelius Robert JamesDirector11/05/20119,450
Rudelius Robert JamesDirector11/02/201112,325
Rudelius Robert JamesDirector11/01/20111,350
Freitag Gregory GeneCFO11/22/201126,250
Freitag Gregory GeneCFO11/21/201117,395
Grooms Jamie MarkDirector10/10/201115,001
Rudelius Robert JamesDirector10/10/201115,001
Harper John FrederickDirector10/10/201115,001
Mandato Joseph MDirector10/10/201115,001
Gold Mark StephenDirector10/10/201115,001
Hopfenspirger Larry10% Owner09/28/201136,200
Load More Insider Transactions
FUNDS WITH A POSITION IN AXOGEN INC.
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.3,342,7730.00058%3.03%Other
GEODE CAPITAL MANAGEMENT, LLC896,3360.00064%5.61%Other
D. E. SHAW & CO., INC.610,9880.00365%6.18%Other
UBS OCONNOR LLC137,5750.07%-42.48%Value
RENAISSANCE TECHNOLOGIES LLC108,6000.00115%NewOther
KEELEY-TETON ADVISORS, LLC84,7250.07%135.35%Value
AQR CAPITAL MANAGEMENT LLC42,5690.00044%ExitedOther
FISHER ASSET MANAGEMENT, LLC1810%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR AXOGEN INC.
STOCK BUYBACKS FOR AXOGEN INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.07%
1Q
12/31/2023
06/30/2023
0.44%
2Q
12/31/2023
03/31/2023
1.13%
3Q
12/31/2023
12/31/2022
1.75%
4Q
12/31/2023
09/30/2022
1.97%
5Q
12/31/2023
06/30/2022
2.51%
6Q
12/31/2023
03/31/2022
2.98%
7Q
12/31/2023
12/31/2021
3.49%
8Q
12/31/2023
09/30/2021
3.82%
9Q
12/31/2023
06/30/2021
4.79%
10Q
12/31/2023
03/31/2021
5.76%
11Q
12/31/2023
12/31/2020
6.96%
12Q
12/31/2023
09/30/2020
7.37%
13Q
12/31/2023
06/30/2020
8.10%
14Q
12/31/2023
03/31/2020
8.45%
15Q
12/31/2023
12/31/2019
9.03%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.07%
1Q
06/30/2023
0.44%
2Q
03/31/2023
1.13%
3Q
12/31/2022
1.75%
4Q
09/30/2022
1.97%
5Q
06/30/2022
2.51%
6Q
03/31/2022
2.98%
7Q
12/31/2021
3.49%
8Q
09/30/2021
3.82%
9Q
06/30/2021
4.79%
10Q
03/31/2021
5.76%
11Q
12/31/2020
6.96%
12Q
09/30/2020
7.37%
13Q
06/30/2020
8.10%
14Q
03/31/2020
8.45%
15Q
12/31/2019
9.03%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AXOGEN INC.
LOADING...